<DOC>
	<DOCNO>NCT01675570</DOCNO>
	<brief_summary>The primary purpose study ass efficacy , tolerability safety RX-10045 Ophthalmic Solution patient Dry Eye Disease .</brief_summary>
	<brief_title>A Study RX-10045 Treatment Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>1 . Have patient report history dry eye eye 2 . Presence dry eye symptom 3 . Presence dry eye sign , destabilize tear film breakup time corneal stain 1 . Known contraindication sensitivity study medication component 2 . Any ocular condition , opinion investigator , could affect subject 's safety trial parameter 3 . Use disallowed medication period indicate prior enrollment study 4 . Be female currently pregnant , plan pregnancy , lactating , use medically acceptable form birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>RX-10045</keyword>
	<keyword>Dry Eye Disease</keyword>
</DOC>